Australia advanced liver cancer market is witnessing a decisive transformation as medical science, targeted therapies and healthcare accessibility converge to...
Credit: CC0 Public Domain It can be challenging to identify which patients with advanced chronic kidney disease (CKD) will most...
Adding Tecentriq (atezolizumab) to Tecentriq plus Avastin (bevacizumab) and tiragolumab treatment did not show an added benefit in patients with...
The final studies (25–32) comprised data from five countries: USA (3), UK (2), China (1), Australia (1), and Canada (1)....
Credit: Ivan Samkov from Pexels An interdisciplinary research team has demonstrated a durable and lasting response to a novel treatment—combined...
A3 UK 2025 Global Liver Institute and King’s College Hospital NHS Foundation Trust are launching the first Advanced Advocacy Academy...
